Inflection Point Acquisition (NASDAQ:IPAX) Shares Up 3.4% - Here's Why - MarketBeat19 hours ago • Google News
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate - PR Newswire2025-04-15 • Google News
Telix sees more backing for LAT1 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline2025-04-16 • Google News